HIGHLIGHTS
- who: M J Kersten from the MJ Kersten1, W Kraan2, J Doorduijn3, J Bromberg4, K Lam5, PM Kluin6, BJ van der Holt7, M Spaargaren2, and ST Pals2, , Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands have published the article: Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations, in the Journal: (JOURNAL)
- what: These findings support the concept that IP-DLBCLs present a pathogenetically distinct group of lymphomas and the authors propose that mutational activation of TLR/MYD88-signaling endows lymphoma-initiating cells with a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.